Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model.

Yakkundi P, Gonsalves E, Galou-Lameyer M, Selby MJ, Chan WK.

Hypoxia (Auckl). 2019 Apr 10;7:1-16. doi: 10.2147/HP.S196301. eCollection 2019.

2.

New epitopes in ovalbumin provide insights for cancer neoepitopes.

Karandikar SH, Sidney J, Sette A, Selby MJ, Korman AJ, Srivastava PK.

JCI Insight. 2019 Mar 14;5. pii: 127882. doi: 10.1172/jci.insight.127882.

3.

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG.

Clin Cancer Res. 2018 Oct 15;24(20):5058-5071. doi: 10.1158/1078-0432.CCR-17-3427. Epub 2018 Jun 13.

PMID:
29898992
4.

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models.

Lewis KE, Selby MJ, Masters G, Valle J, Dito G, Curtis WR, Garcia R, Mink KA, Waggie KS, Holdren MS, Grosso JF, Korman AJ, Jure-Kunkel M, Dillon SR.

Oncoimmunology. 2017 Oct 4;7(1):e1377873. doi: 10.1080/2162402X.2017.1377873. eCollection 2017.

5.

Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model.

Shen YC, Ghasemzadeh A, Kochel CM, Nirschl TR, Francica BJ, Lopez-Bujanda ZA, Carrera Haro MA, Tam A, Anders RA, Selby MJ, Korman AJ, Drake CG.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):113-125. doi: 10.1038/s41391-017-0013-x. Epub 2017 Dec 4.

6.

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.

Noguchi T, Ward JP, Gubin MM, Arthur CD, Lee SH, Hundal J, Selby MJ, Graziano RF, Mardis ER, Korman AJ, Schreiber RD.

Cancer Immunol Res. 2017 Feb;5(2):106-117. doi: 10.1158/2326-6066.CIR-16-0391. Epub 2017 Jan 10.

7.

Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Nov 18;11(11):e0167251. doi: 10.1371/journal.pone.0167251. eCollection 2016.

8.

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Sep 9;11(9):e0161779. doi: 10.1371/journal.pone.0161779. eCollection 2016. Erratum in: PLoS One. 2016 Nov 18;11(11):e0167251.

9.

In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.

Wang C, Thudium KB, Han M, Wang XT, Huang H, Feingersh D, Garcia C, Wu Y, Kuhne M, Srinivasan M, Singh S, Wong S, Garner N, Leblanc H, Bunch RT, Blanset D, Selby MJ, Korman AJ.

Cancer Immunol Res. 2014 Sep;2(9):846-56. doi: 10.1158/2326-6066.CIR-14-0040. Epub 2014 May 28.

10.

Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.

Selby MJ, Engelhardt JJ, Quigley M, Henning KA, Chen T, Srinivasan M, Korman AJ.

Cancer Immunol Res. 2013 Jul;1(1):32-42. doi: 10.1158/2326-6066.CIR-13-0013. Epub 2013 Apr 7.

11.

Antifeedant compounds from three species of Apiaceae active against the field slug, Deroceras reticulatum (Muller).

Birkett MA, Dodds CJ, Henderson IF, Leake LD, Pickett JA, Selby MJ, Watson P.

J Chem Ecol. 2004 Mar;30(3):563-76.

PMID:
15139308
12.

Synthesis of a novel hepatitis C virus protein by ribosomal frameshift.

Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, Chien D, Selby MJ, Ou J.

EMBO J. 2001 Jul 16;20(14):3840-8.

13.

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.

Weiner AJ, Paliard X, Selby MJ, Medina-Selby A, Coit D, Nguyen S, Kansopon J, Arian CL, Ng P, Tucker J, Lee CT, Polakos NK, Han J, Wong S, Lu HH, Rosenberg S, Brasky KM, Chien D, Kuo G, Houghton M.

J Virol. 2001 Aug;75(15):7142-8.

14.

Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection.

Paliard X, Doe B, Selby MJ, Hartog K, Lee AY, Burke RL, Walker CM.

Virology. 2001 Mar 30;282(1):56-64.

15.

Relative potency of cellular and humoral immune responses induced by DNA vaccination.

Otten GR, Doe B, Schaefer M, Chen M, Selby MJ, Goldbeck C, Hong M, Xu F, Ulmer JB.

Intervirology. 2000;43(4-6):227-32.

PMID:
11251378
16.

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.

Polakos NK, Drane D, Cox J, Ng P, Selby MJ, Chien D, O'Hagan DT, Houghton M, Paliard X.

J Immunol. 2001 Mar 1;166(5):3589-98.

17.

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.

Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen M, Otten GR, Ulmer JB, Donnelly JJ, Ott G, McDonald DM.

J Immunol. 2000 Sep 1;165(5):2850-8.

18.

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, Leung L, Otten GR, Thudium K, Selby MJ, Ulmer JB.

J Immunol. 2000 May 1;164(9):4635-40.

19.

Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein.

Liberman E, Fong YL, Selby MJ, Choo QL, Cousens L, Houghton M, Yen TS.

J Virol. 1999 May;73(5):3718-22.

20.

Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis.

Selby MJ, Ling N, Williams JM, Dawson A.

Percept Mot Skills. 1998 Jun;86(3 Pt 1):1099-106.

PMID:
9656314
21.

Assessment of memory in multiple sclerosis patients using the Memory Assessment Scale.

Ling ND, Selby MJ.

Percept Mot Skills. 1998 Jun;86(3 Pt 1):987-98.

PMID:
9656299
22.

Neuropsychological functioning in drug abusers.

Selby MJ, Azrin RL.

Drug Alcohol Depend. 1998 Mar 1;50(1):39-45.

PMID:
9589271
24.
25.
26.
27.

Hostility in depression.

Moreno JK, Selby MJ, Fuhriman A, Laver GD.

Psychol Rep. 1994 Dec;75(3 Pt 1):1391-401.

PMID:
7892410
28.

Complex processing and protein:protein interactions in the E2:NS2 region of HCV.

Selby MJ, Glazer E, Masiarz F, Houghton M.

Virology. 1994 Oct;204(1):114-22.

PMID:
8091646
29.

Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.

Ghosh S, Selby MJ, Peterlin BM.

J Mol Biol. 1993 Dec 5;234(3):610-9.

PMID:
8254663
30.

Measurement of hostility, anger, and depression in depressed and nondepressed subjects.

Moreno JK, Fuhriman A, Selby MJ.

J Pers Assess. 1993 Dec;61(3):511-23.

PMID:
8295113
31.

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome.

Selby MJ, Choo QL, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C, Houghton M.

J Gen Virol. 1993 Jun;74 ( Pt 6):1103-13.

PMID:
8389800
33.

Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.

Selby MJ, Peterlin BM.

Cell. 1990 Aug 24;62(4):769-76.

PMID:
2117500
35.

Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector.

Edwards RH, Selby MJ, Mobley WC, Weinrich SL, Hruby DE, Rutter WJ.

Mol Cell Biol. 1988 Jun;8(6):2456-64.

36.

Processing of the native nerve growth factor precursor to form biologically active nerve growth factor.

Edwards RH, Selby MJ, Garcia PD, Rutter WJ.

J Biol Chem. 1988 May 15;263(14):6810-5.

37.

Mouse nerve growth factor gene: structure and expression.

Selby MJ, Edwards R, Sharp F, Rutter WJ.

Mol Cell Biol. 1987 Sep;7(9):3057-64.

38.

Cobra nerve growth factor: structure and evolutionary comparison.

Selby MJ, Edwards RH, Rutter WJ.

J Neurosci Res. 1987;18(2):293-8.

PMID:
3694712
39.

Isolation of complementary DNA encoding mouse nerve growth factor and epidermal growth factor.

Scott J, Selby MJ, Bell GI.

Methods Enzymol. 1987;147:194-207. No abstract available.

PMID:
3499557
40.

Differential RNA splicing predicts two distinct nerve growth factor precursors.

Edwards RH, Selby MJ, Rutter WJ.

Nature. 1986 Feb 27-Mar 5;319(6056):784-7.

PMID:
2419763
41.

Analysis of a major human chorionic somatomammotropin gene. Evidence for two functional promoter elements.

Selby MJ, Barta A, Baxter JD, Bell GI, Eberhardt NL.

J Biol Chem. 1984 Nov 10;259(21):13131-8.

42.
43.

The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences.

Bell GI, Selby MJ, Rutter WJ.

Nature. 1982 Jan 7;295(5844):31-5. No abstract available.

PMID:
7035959
44.
45.

Possible tertiary age for some antarctic cirques.

Selby MJ, Wilson AT.

Nature. 1971 Feb 26;229(5287):623-4. No abstract available.

PMID:
16059388
46.

A digital recording system for Fourier transform spectrometry.

Ibbett RN, Selby MJ.

J Sci Instrum. 1968 Jul;1(7):745-8. No abstract available.

PMID:
5703443
47.

The chronic oral toxicity of benzylpenicillin.

BOYD EM, SELBY MJ.

Antibiot Chemother (Northfield). 1962 Apr;12:249-62. No abstract available.

PMID:
13872145

Supplemental Content

Loading ...
Support Center